UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Belantamab mafodotin-blmf (Blenrep)
Situation
Belantamab mafodotin-blmf (Blenrep) intravenous solution was approved for removal from the health system formulary at the January 2023 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: belantamab mafodotin-blmf (Blenrep) 100 mg intravenous solution
Assessment/Recommendations
System P&T voted to remove the following products on the UNC Health System Drug Formulary:
- Belantamab mafodotin-blmf (Blenrep) 100 mg intravenous solution
Formulary/Epic changes will Go-Live on Tuesday, February 28, 2023.